http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#Head http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#assertion http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#provenance http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#pubinfo http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#assertion http://purl.obolibrary.org/obo/DOID_2965 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_2965 http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00328 http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association http://www.w3.org/2000/01/rdf-schema#label carefully consider the potential benefits and risks of indomethacin extended release capsules usp 75 mg and other treatment options before deciding to use indomethacin extended release capsules usp 75 mg use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings indomethacin extended release capsules usp 75 mg has been found effective in active stages of the following 1 moderate to severe rheumatoid arthritis including acute flares of chronic disease 2 moderate to severe ankylosing spondylitis 3 moderate to severe osteoarthritis 4 acute painful shoulder bursitis and or tendinitis indomethacin extended release capsules usp 75 mg are not recommended for the treatment of acute gouty arthritis indomethacin may enable the reduction of steroid dosage in patients receiving steroids for the more severe forms of rheumatoid arthritis in such instances the steroid dosage should be reduced slowly and the patients followed very closely for any possible adverse effects the use of indomethacin in conjunction with aspirin or other salicylates is not recommended controlled clinical studies have shown that the combined use of indomethacin and aspirin does not produce any greater therapeutic effect than the use of indomethacin alone furthermore in one of these clinical studies the incidence of gastrointestinal side effects was significantly increased with combined therapy see precautions drug interactions http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00328 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#provenance http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#pubinfo http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig http://purl.org/nanopub/x/hasSignature Uq+QYY0+7BbOkOyqXC3BAPdPNy9JqPad6CqKXJaCTyLSzda8k2PpZx6x3ivooSFS9TlISED75BH48R3IfCfO23FvHtVtbLE8kFe+DMUjfHyrJlB3gZ9M+gTwvCxtwBmQdpCq8/XEJNp56/iJT15gB7Qlx5wCqaVqjE+QNjFoBnM= http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g http://purl.org/dc/terms/created 2021-06-13T12:42:24.333+02:00 http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs